Details

Last Funding Type

Seed

Last Funding Money Raised

$1.70M

Industries

Biotechnology,Health Care,Therapeutics

Founded date

Jan 1, 2008

Number Of Employee

1 - 10

Operating Status

Active

Ophidion is a biotechnology company that delivers a central nervous system therapeutics to targeted sites in the brain. The company uses a Trojan horse strategy to exploit an endogenous receptor-mediated transport system to deliver small molecule drugs and biologics into the brain. They are currently focused on developing a pipeline to deliver gene-silencing therapies to treat neurodegenerative diseases, including diseases of Cognitive Impairment (e.g. Alzheimer’s disease, Parkinson’s disease) as well as Huntington’s disease.

Ophidion platform technology is amenable to delivering multiple classes of drugs, including small molecules and macromolecules (gene therapeutics, siRNA’s, antibodies, peptides, and other macromolecules). It also has an advanced program that is positioned to start pivotal clinical trials to treat anxiety-related disorders, together with a patented companion biomarker diagnostic to select the appropriate patient population.